Eric Lefkofsky is an American entrepreneur who has founded many successful business ventures. He recently cofounded Tempus, Inc, where he serves as the Chief Executive Officer. The goal of starting Tempus is to create an extensive database of cancer patients that doctors can use as a reference to cure others in future. He got the drive to help other cancer patients to be cured successfully when his wife had breast cancer. Eric noticed that most hospitals did not have the required data to use in the treatment of disease. He acknowledged that these physicians could make better treatments if they had data to refer to hence Tempus was established.
Tempus is a technological company that focuses on amassing tons of clinical and genomic data from treatments of cancer patients and making that data available to multiple users. To achieve this, they are building the World’s most extensive library of molecular and clinical data with an efficient operating system. This data will enable doctors to borrow insight to treat their patients from previous similar cases. The company analyses a person’s genomic structure to understand it at a molecular level and also compile other patient reports like scans, pathology images, clinical notes and lab reports.
This data is then analysed in their platform to enable physicians to make decisions based on data. In his latest fundraiser for Tempus, Eric Lefkofsky has raised over $70 million from investors who support his mission of curing cancer. With millions of people affected by cancer, Tempus faces stiff competition that they will survive due to their meaningful purpose. Eric is a philanthropist who supports charitable, educational and scientific causes around the world through his philanthropic fund, the Lefkofsky Foundation. The fund has helped more than 50 organisations achieve their goals. He is a trustee to various organisations and a part-time professor at the University of Chicago.